Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations
V. Bonetto, L. Pasetto, I. Lisi, M. Carbonara, R. Zangari, E. Ferrari, V. Punzi, S. Luotti, N. Bottino, B. Biagianti, C. Moglia, G. Fuda, R. Gualtierotti, F. Blasi, C. Canetta, N. Montano, M. Tettamanti, G. Camera, M. Grimoldi, G. Negro, N. Rifino, A. Calvo, P. Brambilla, F. Biroli, A. Bandera, A. Nobili, N. Stocchetti, M. Sessa, E.R. Zanier
doi: https://doi.org/10.1101/2022.09.26.22280358
V. Bonetto
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
L. Pasetto
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
I. Lisi
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
M. Carbonara
2Department of Pathophysiology and Transplants, University of Milan, Milan, Italy
R. Zangari
3FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy
E. Ferrari
2Department of Pathophysiology and Transplants, University of Milan, Milan, Italy
V. Punzi
2Department of Pathophysiology and Transplants, University of Milan, Milan, Italy
S. Luotti
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
N. Bottino
4Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
B. Biagianti
5Department of Neurosciences and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
C. Moglia
6“Rita Levi Montalcini”, Department of Neuroscience, University of Turin, Turin, Italy
G. Fuda
6“Rita Levi Montalcini”, Department of Neuroscience, University of Turin, Turin, Italy
R. Gualtierotti
7Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
F. Blasi
8Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
C. Canetta
9Acute Internal Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
N. Montano
10UOC Internal Medicine, Immunology and Allergology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
M. Tettamanti
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
G. Camera
11Department of Neurology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy
M. Grimoldi
11Department of Neurology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy
G. Negro
12Neurology Section, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
N. Rifino
13Division of Neurology, University of Milano-Bicocca, Milan, Italy
A. Calvo
6“Rita Levi Montalcini”, Department of Neuroscience, University of Turin, Turin, Italy
P. Brambilla
2Department of Pathophysiology and Transplants, University of Milan, Milan, Italy
5Department of Neurosciences and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
F. Biroli
3FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy
A. Bandera
14Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
A. Nobili
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
N. Stocchetti
2Department of Pathophysiology and Transplants, University of Milan, Milan, Italy
M. Sessa
11Department of Neurology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy
E.R. Zanier
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy

Article usage
Posted September 26, 2022.
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations
V. Bonetto, L. Pasetto, I. Lisi, M. Carbonara, R. Zangari, E. Ferrari, V. Punzi, S. Luotti, N. Bottino, B. Biagianti, C. Moglia, G. Fuda, R. Gualtierotti, F. Blasi, C. Canetta, N. Montano, M. Tettamanti, G. Camera, M. Grimoldi, G. Negro, N. Rifino, A. Calvo, P. Brambilla, F. Biroli, A. Bandera, A. Nobili, N. Stocchetti, M. Sessa, E.R. Zanier
medRxiv 2022.09.26.22280358; doi: https://doi.org/10.1101/2022.09.26.22280358
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations
V. Bonetto, L. Pasetto, I. Lisi, M. Carbonara, R. Zangari, E. Ferrari, V. Punzi, S. Luotti, N. Bottino, B. Biagianti, C. Moglia, G. Fuda, R. Gualtierotti, F. Blasi, C. Canetta, N. Montano, M. Tettamanti, G. Camera, M. Grimoldi, G. Negro, N. Rifino, A. Calvo, P. Brambilla, F. Biroli, A. Bandera, A. Nobili, N. Stocchetti, M. Sessa, E.R. Zanier
medRxiv 2022.09.26.22280358; doi: https://doi.org/10.1101/2022.09.26.22280358
Subject Area
Subject Areas
- Addiction Medicine (576)
- Allergy and Immunology (867)
- Anesthesia (306)
- Cardiovascular Medicine (4480)
- Dermatology (385)
- Emergency Medicine (614)
- Epidemiology (15276)
- Forensic Medicine (31)
- Gastroenterology (1133)
- Genetic and Genomic Medicine (6644)
- Geriatric Medicine (671)
- Health Economics (1006)
- Health Informatics (4603)
- Health Policy (1378)
- Hematology (544)
- HIV/AIDS (1275)
- Medical Education (626)
- Medical Ethics (147)
- Nephrology (674)
- Neurology (6693)
- Nursing (346)
- Nutrition (1006)
- Obstetrics and Gynecology (1152)
- Oncology (3369)
- Ophthalmology (988)
- Orthopedics (370)
- Otolaryngology (421)
- Pain Medicine (437)
- Palliative Medicine (131)
- Pathology (668)
- Pediatrics (1703)
- Primary Care Research (717)
- Public and Global Health (9285)
- Radiology and Imaging (2223)
- Respiratory Medicine (1201)
- Rheumatology (598)
- Sports Medicine (535)
- Surgery (720)
- Toxicology (100)
- Transplantation (290)
- Urology (267)




